Rittenhouse Ventures is a Philadelphia-based venture capital firm that focuses on early-stage investments in technology businesses, providing expertise and financial support to entrepreneurs.

Rittenhouse Ventures

VIDA focuses on accelerating respiratory clinical trials through data-driven clinical trial methodologies, including optimized imaging operations and data insights.

VIDA

BioAdvance is a venture capital firm that provides funding and business development services to early-stage life sciences and healthcare companies. The firm focuses on opportunities within the Mid-Atlantic region, aiming to accelerate the growth of innovative startups in the biotechnology, pharmaceutical, medical device, and healthcare IT sectors.

Gregory Harriman

Barbara S. Schilberg

BioAdvance

Dreamit Ventures invests in transformative early-stage companies focused on scaling revenues. It specializes in cybersecurity, anti-fraud, risk & compliance, and physical security companies.

Dreamit Ventures

Rittenhouse Ventures | 857 followers on LinkedIn. Rittenhouse Ventures is a Philadelphia-based, emerging-growth venture capital firm founded in 2008. | Rittenhouse Ventures is an emerging growth venture fund focused on innovative software solutions that power enterprises in healthcare, life sciences, financial services, human resources, and general business services. 

With a unique combination of right-sized investments, deep expertise, and a proven track record, we optimize capital and growth strategies for entrepreneurs. 

Based in Philadelphia and investing across the Mid-Atlantic region, we build long-term partnerships with entrepreneurs, leveraging our extensive local network to our portfolio&#39;s advantage.

Keith Scandone

David Nevas

Partner at Rittenhouse Ventures

Bruce Luehrs

External Rep at Pando

Justin Hanley

Our portfolio company HRSoft continues to revolutionize the #CompensationManagement space.

Congratulations to our portfolio company Pieces on being selected for an NIH grant.

Great to see such impressive patient results at our portfolio company Cecelia Health

Exciting to see HRSoft getting recognized for its rapid growth. Exciting times in the Rittenhouse Ventures portfolio.

Metric
Company Name	Rittenhouse Ventures	VIDA	BioAdvance	Dreamit Ventures
Symbol
MSH ID	COM:RITTENHOUSEVENTURES	AI:VIDALUNG	COM:BIOADVANCE	COM:DREAMIT
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Financial Services & Finance	Healthcare & Health Services	Healthcare & Health Services	Financial Services & Finance
Industry	Venture Capital	Medical Technology	Healthcare & Health Services	Venture Capital
Country	US	US		US
Stage		Venture Round	Grant
Employee Count			52
Website	rittenhouseventures.com	vidalung.ai	bioadvance.com	dreamit.com
LinkedIn	rittenhousevc	vidalung	bioadvance
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	4.44K	42
Web Traffic Growth	-0.76	-0.97
Valuation
Raised Capital	10.82M	14.76M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

RITT

COM:RITTENHOUSEVENTURES

Rittenhouse Ventures

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue